NoHo Partners' Q4 2024 results came in clearly above Vara Research consensus, as the company continu...
Small beat in Q4 and news of CEO leaving Adj. EBITDA up 2.
On February 12th, Eevia Health Plc (publ) (“Eevia”) announced that the Company has signed a term she...
Etteplan’s Q4 performance aligned with our expectations.
Marimekko reports its Q4/24 figures on 19th of February.
Q4 report Wednesday, 19 February at 08:30 CET '24e EBITA up 4% 25-9x EBITA in '24e-'26e, 5-18% FCF y...
NoHo Partners reported Q4 EBIT of EUR 15.1m (+42%% y/y), 19% above Vara Research consensus and 13% a...
Taaleri’s group continuing earnings grew 6% y/y to EUR 10.
Sprint Bioscience delivered Q4 sales within the recent range at SEK 16.
Pirepemat topline data coming closer IRL757 passes Ph 1 successfully Webcast today at 10:00 CET Eve...
Nettoomsättningen för det tredje kvartalet uppgick till 119,6 MSEK (99,8), vilket motsvarade en orga...
Redeye retains its positive view of Sdiptech following a stable Q4 report.
EBITA grew 37% y-o-y Sees positive signals in the Swedish project market Trading at 9x '25e EV/EBITA...
Beat on adj. EBIT but lower OCF Adj. EBIT up 8.9-9.
Q4 better than expected, adj. EBITA +0-2% Financial flexibility for divi, buybacks & M&A with curren...
